| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff81a650b70e913d3b2524b45e4c7320
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dafce8eb24008df95060a67327ed4ecc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4b5babc6880950c3172dbd3039f78cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43b8f22d6e7582509f8893f195a00dcb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
| filingDate |
2017-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55c7c6f76aa66631f445b12dfe796e8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcea7a049a9e10b69a874de6924e1769
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_651ac8478ab81190f5112ae2de21da55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc2c98c5b6563dbf906358642b0ec677
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80f1d918443ac8cef682937a691e1f64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7223a166595a099a6507d62d0d2b8acb |
| publicationDate |
2021-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11033615-B2 |
| titleOfInvention |
Zika virus vaccine and methods of production |
| abstract |
The invention generally relates to a purified inactivated Zika virus (ZIKV), methods for producing the purified inactivated ZIKV, immunogenic compositions and vaccines comprising the purified inactivated ZIKV and methods for the prevention and/or treatment of infection by ZIKV. |
| priorityDate |
2016-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |